Therefore, with the introduction of a catechol moiety, we obtained AP2469 that possesses anti-AChE and anti-BACE1 activities, and shows an enlarged activity profile able to interact with other key targets for AD. This evidence concerns the gene ACHE and Alzheimer disease.